Determining the point of indifference - Where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise [2]

Indian Journal of Gastroenterology

Volumn 23, Issue 4, 2004, Pages 154-156

  Varghese, R Mathew ^a   Abraham, Jacob ^a   James, Jyotsna ^a   Puliyel, Jacob M ^a  

^a ST STEPHEN S HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEPATITIS B; HUMAN; IMMUNIZATION; INDIA; LETTER; PREGNANCY; SENSITIVITY ANALYSIS;

ADULT; COST SAVINGS; COST-BENEFIT ANALYSIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION PROGRAMS; INDIA; INFANT, NEWBORN; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT;

EID: 4344626391     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Mittal SK, Rao S, Rastogi A, Aggarwal V, Kumari S. Hepatitis B: potential for perinatal transmission in India. Trop Gastroenterol 1996;17:190-2.
2. Abbas F, Thomas RD, Rajkumar A, Gupta N, Puliyel JM. Controlling perinatally acquired hepatitis B. Indian J Pediatrics 2001;68:365.
3. Lodha R, Jain Y, Anand K, Kabra SK, Pandav CS. Hepatitis B in India: review of disease epidemiology. Indian Pediatr 2001;38:349-71.
4. Tyagi V, Singh SK, Sawhney A, Taneja V, Puliyel JM. Using GNP to calculate acceptable immunization costs: deploying cost effectiveness calculations in reverse. Pharmacoeconomics 2003;21:497-9.
5. Greenhalgh T. How to read a paper: papers that tell you what things cost (economic analysis). Br Med J 1997;315:596-9.